Petra Kukkaro, Sundeep Chaitanya Vedithi, David J Blok, Wim H van Brakel, Annemieke Geluk, Aparna Srikantam, David Scollard, Linda B Adams, Mathias Duck, Sunil Anand, Andie Tucker, Israel Cruz, Vrr Pemmaraju, Daniel Argaw Dagne, Kingsley Asiedu, Christopher Hanna
The World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to guide multidrug treatment initiation...
April 1, 2024: Bulletin of the World Health Organization